← The Wire
EQNasdaq
Equillium, Inc.
Pharmaceutical Preparations · DE · CIK 1746466
Equillium develops novel therapies for severe autoimmune and inflammatory disorders, advancing EQ504
$178M
Market cap
$3.08
Last close
+1.0%
1D
+7.7%
5D
447K
Volume
Price · last 39 sessions+46.7%
May 4L $1.76 · H $3.17Jun 29
180
Total filings
May 29, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 29, 202610-Q10-QMay 13, 20268-KResults of OperationsMay 13, 2026DEFA14ADEFA14AApr 15, 2026DEF 14ADEF 14AApr 15, 202610-K10-KMar 25, 20268-KResults of OperationsMar 25, 20268-KMaterial Agreement · Equity IssuanceMar 13, 202610-Q10-QNov 13, 20258-KResults of OperationsNov 13, 20258-K/AAuditor ChangeOct 24, 20258-KAuditor Change · Executive ChangeOct 6, 20258-KCompany UpdateSep 19, 2025424B5424B5Sep 19, 20258-KCompany UpdateSep 4, 202510-Q10-QAug 14, 20258-KMaterial Agreement · Equity IssuanceAug 11, 20258-KMaterial Agreement · Results of OperationsAug 4, 20258-KDelisting NoticeJun 13, 20258-KExecutive Change · Shareholder VoteMay 22, 202510-Q10-QMay 14, 20258-KResults of OperationsApr 24, 2025DEFA14ADEFA14AApr 10, 2025DEF 14ADEF 14AApr 10, 202510-K10-KMar 27, 20258-KResults of OperationsMar 27, 20258-KCompany UpdateFeb 6, 20258-KDelisting NoticeDec 13, 20248-KExecutive ChangeDec 12, 202410-Q10-QNov 13, 20248-KResults of OperationsNov 13, 20248-KCompany UpdateOct 31, 20248-KCompany UpdateOct 31, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KDelisting NoticeJul 23, 20248-KResults of OperationsJul 18, 20248-KCompany UpdateJun 4, 20248-KShareholder VoteMay 23, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 11, 2024DEF 14ADEF 14AApr 11, 20248-KCompany UpdateApr 1, 202410-K10-KMar 25, 20248-KResults of OperationsMar 25, 20248-KExecutive Change · Company UpdateMar 8, 20248-KResults of Operations · Company UpdateFeb 23, 2024424B5424B5Feb 23, 20248-KCompany UpdateFeb 22, 20248-KCompany UpdateDec 21, 202310-Q10-QNov 8, 20238-KResults of Operations · Company UpdateNov 8, 20238-KReg FD Disclosure · Company UpdateOct 16, 20238-KDelisting Notice · Material AgreementOct 5, 2023424B5424B5Oct 5, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KAgreement TerminatedMay 25, 20238-KShareholder VoteMay 23, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEFA14ADEFA14AApr 13, 2023DEF 14ADEF 14AApr 11, 20238-KDelisting NoticeApr 6, 202310-K10-KMar 23, 20238-KResults of OperationsMar 23, 20238-KAgreement Terminated · Shareholder VoteDec 23, 2022425425Dec 15, 20228-KCompany UpdateDec 15, 2022425425Dec 6, 2022425425Dec 6, 20228-KMaterial Agreement · Company UpdateDec 6, 202210-Q10-QNov 14, 2022425425Nov 14, 20228-KResults of OperationsNov 14, 2022S-4S-4Oct 27, 2022425425Sep 28, 2022425425Sep 27, 20228-KCompany UpdateSep 27, 2022
Insider Activity
In the 90 days to Mar 13, 2026: 2 sold $1.5M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2026 | Zedelmayer ChristineSr. Vice President and COO | Sell | 120,312 | $2.50 | $301K |
| Mar 9, 2026 | Zedelmayer ChristineSr. Vice President and COO | Sell | 181,219 | $2.00 | $362K |
| Feb 19, 2026 | Zedelmayer ChristineSr. Vice President and COO | Sell | 109,375 | $1.78 | $195K |
| Feb 19, 2026 | Zedelmayer ChristineSr. Vice President and COO | Sell | 109,375 | $1.78 | $195K |
| Feb 19, 2026 | Zedelmayer ChristineSr. Vice President and COO | Sell | 76,562 | $1.74 | $133K |
| Feb 19, 2026 | Zedelmayer ChristineSr. Vice President and COO | Sell | 76,562 | $1.74 | $133K |
| Jan 8, 2026 | Tom PennyPrincipal Accounting Officer | Sell | 6,533 | $1.29 | $8K |
| Dec 23, 2025 | Zedelmayer ChristineSr. Vice President and COO | Sell | 100,000 | $1.50 | $150K |
| Dec 15, 2025 | Zedelmayer ChristineSr. Vice President and COO | Sell | 11,900 | $1.31 | $16K |
| Dec 12, 2025 | Zedelmayer ChristineSr. Vice President and COO | Sell | 23,804 | $1.34 | $32K |
| Nov 25, 2025 | Zedelmayer ChristineSr. Vice President and COO | Sell | 7,998 | $0.95 | $8K |
| Nov 25, 2025 | Zedelmayer ChristineSr. Vice President and COO | Sell | 100 | $0.98 | $98 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance